Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32750
Title: Immune mediated colitis: a surgical perspective.
Austin Authors: Le, Khang Duy Ricky;Choy, Kay-Tai ;Roth, Sara;Heriot, Alexander G;Kong, Joseph C H
Affiliation: Department of General Surgical Specialties, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Surgery
Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Geelong Clinical School, Deakin University, Geelong, Victoria, Australia.
Issue Date: Jun-2023
Date: 2023
Publication information: ANZ Journal of Surgery 2023; 93(6)
Abstract: This study aims to review and summarize the current up to date literature that explore the current treatment approaches to immune mediated colitis and the role of surgical specialties in the landscape of management. A narrative review of papers was performed following a literature search through Medline, EMBASE and Cochrane Central databases pertaining to immune mediated colitis as an adverse event of cancer immunotherapy. Current guidelines for the diagnosis and treatment of immune mediated colitis mirror the approach to the workup of inflammatory bowel disease and guided by treating oncology and gastroenterology specialties. Immune mediated colitis however relies on surgical specific skills as a consequence of obtaining a diagnosis as well as in the management of complications that may arise. Immune mediate colitis management has largely been under the purview of medical specialties. This review explores the current landscape of managing immune mediated colitis from a surgical perspective and highlights key areas in which surgeons can engage in the multidisciplinary care of this condition. To facilitate prompt diagnosis and management of immune-mediated colitis, there is an increasing necessity for surgeons to become familiar with the latest multidisciplinary approaches and recommendations.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32750
DOI: 10.1111/ans.18485
ORCID: 0000-0003-4532-8248
0000-0001-5763-5742
0000-0001-9846-8776
0000-0002-1392-2480
Journal: ANZ Journal of Surgery
PubMed URL: 37088921
ISSN: 1445-2197
Type: Journal Article
Subjects: checkpoint inhibitor induced colitis
checkpoint inhibitors
colon
cytotoxic T-lymphocyte associated antigen 4
immune checkpoint inhibitors
immune mediated colitis
immune related adverse events
immune therapy
immunotherapy
immunotherapy induced colitis
programmed cell death protein 1
programmed death ligand 1
Appears in Collections:Journal articles

Show full item record

Page view(s)

20
checked on Nov 14, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.